We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AYUSH-64

News List

Government transfers AYUSH-64 COVID drug technology to 46 companies to meet growing demand ExpressPharma
November 22, 2021
The Central Council for Research in Ayurvedic Sciences (CCRAS) has transferred the technology of AYUSH-64, an “effective” drug in mild and asymptomatic and mild-to-moderate cases of COVID-19...
Government releases ‘National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19’ expresspharma
August 05, 2021
The Government of India has released the “National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19” prepared by the National Task force in consensus from various expert committees, informed Sarbananda Sonowal ...
Centre allows research on AYUSH Medicines to curb COVID-19 expresspharma
July 22, 2021
States/UTs licensing authorities have been requested to expedite the process of the licensing/approval of applications for the manufacturing of AYUSH-64, Minister of State for AYUSH informed Rajya Sabha 20th.